Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
8.12
+0.04 (0.56%)
Jun 1, 2026, 1:28 PM EDT - Market open
Instil Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -47.38 | -71.37 | -74.14 | -156.09 | -223.18 | -156.79 |
Depreciation & Amortization | 0.05 | 0.53 | 3.61 | 4.76 | 5.99 | 2.75 |
Stock-Based Compensation | 6.18 | 8.69 | 17.26 | 18.17 | 30.44 | 26.2 |
Other Adjustments | 5.39 | 26.09 | 10.18 | 60.15 | 16.15 | 1.35 |
Changes in Accounts Payable | 0.51 | 0.12 | -0.56 | -1.13 | -1.81 | 3.86 |
Changes in Accrued Expenses | -1.28 | -2.35 | -1.9 | -7.77 | -8.98 | 12.05 |
Changes in Other Operating Activities | 1.06 | 1.67 | -10.15 | -0.11 | 1.22 | -11.55 |
Operating Cash Flow | -33.76 | -36.62 | -55.7 | -82.03 | -180.16 | -122.14 |
Capital Expenditures | - | - | - | -20.66 | -84.59 | -57.83 |
Purchases of Intangible Assets | - | -10 | -10 | - | - | - |
Purchases of Investments | -84.98 | -100.86 | -134.01 | -301.47 | -665.05 | -1,108 |
Proceeds from Sale of Investments | 110.5 | 135.9 | 198.1 | 361.7 | 865.35 | 691 |
Other Investing Activities | 0.03 | 0.43 | -0.12 | 1.56 | -1.17 | - |
Investing Cash Flow | 15.55 | 25.48 | 53.97 | 41.13 | 114.54 | -474.4 |
Long-Term Debt Issued | - | - | 85.6 | 8.67 | 70.34 | - |
Long-Term Debt Repaid | - | - | -82.84 | -0.59 | - | - |
Net Long-Term Debt Issued (Repaid) | - | - | 2.76 | 8.08 | 70.34 | - |
Issuance of Common Stock | 3.75 | 7.46 | 0.37 | - | 1.55 | 340.77 |
Net Common Stock Issued (Repurchased) | 3.75 | 7.46 | 0.37 | - | 1.55 | 340.77 |
Issuance of Preferred Stock | - | - | - | - | - | 52.46 |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | - | 52.46 |
Other Financing Activities | - | -0.17 | -1.37 | - | - | -0.07 |
Financing Cash Flow | 7.06 | 7.29 | 1.76 | 8.08 | 71.89 | 393.16 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.03 | 0.02 | -0.09 | -0.2 | -0.64 | -0.3 |
Net Cash Flow | -11.15 | -3.85 | 0.03 | -32.82 | 6.26 | -203.37 |
Free Cash Flow | -33.76 | -36.62 | -55.7 | -102.69 | -264.75 | -179.97 |
Free Cash Flow Per Share | -5.02 | -5.49 | -8.56 | -15.79 | -40.88 | -33.96 |
Levered Free Cash Flow | -47.04 | -71.4 | -80.37 | -172.93 | -241.01 | -207.51 |
Unlevered Free Cash Flow | -54.69 | -78.61 | -82.54 | -184.09 | -312.54 | -206.32 |